Abstract
Purpose
To determine the effectiveness of FDG-PET/CT in the assessment of inguinofemoral lymph node (IFLN) in patients with vulvar cancer by comparing FDG-PET/CT results, sentinel lymph node (SLN) screening with gamma probe, and the results of frozen section and definitive pathology in these lymph nodes.
Study design
This prospective study included eight patients, who were diagnosed with vulvar cancer at the Gynecology and Obstetrics Department of Erciyes University, Turkey. All patients underwent FDG-PET/CT before surgery. Local excision and IFLN dissection were planned by assessing IFLN involvement with SLN screening with Tc-99m nanocolloid plus frozen section. Intraoperatively, SLN screening was performed by using a gamma probe, and these lymph nodes were excised and then evaluated by frozen section. Regardless of the frozen section results, the IFLNs were totally excised. The FDG-PET/CT scan results, SLN plus frozen section results and definitive pathology results of the inguinal lymph nodes were compared.
Results
The mean age was 64.50 ± 13.25 years (min–max 43–79 years). All tumors were squamous cell carcinomas. FDG-PET/CT scan determined vulvar lesions accurately in all patients (8/8; 100 %). When inguinal lymph nodes were assessed by FDG uptake and SUVmax values, lymph nodes were interpreted as reactive in four patients (4/8; 50 %) and metastatic in the others (4/8; 50 %). In all patients frozen section confirmed the FDG-PET–CT results and definitive histopathology results confirmed the frozen section and FDG-PET–CT results (8/8; 100 %).
Conclusions
In light of these data, FDG-PET/CT scanning is an effective method for the detection of primary tumor in vulvar cancer. Although it seems to be an effective method for the detection of IFLN metastasis, these findings must be supported by further studies with larger sample size for use in the planning of primary surgery and inguinal lymph node dissection without SLN dissection and frozen section, as a minimal invasive method.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Zweizig S, Korets S, Cain JM (2014) Key concepts in management of vulvar cancer. Best Pract Res Clin Obstet Gynaecol 28:959–966
Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG (2008) New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol 109:340–345
Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F (1999) Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 17:41–45
Micheletti L, Borgno G, Barbero M, Preti M, Cavanna L, Nicolaci P, Benedetto C, Ghiringhello B, Bocci A (1990) Deep femoral lymphadenectomy with preservation of the fascia lata. Preliminary report on 42 invasive vulvar carcinomas. J Reprod Med 35:1130–1133
Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, Van Dorst EB, Van der Velden J, Hermans RH, van der Putten H, Drouin P, Schneider A, Sluiter WJ (2008) Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 26:884–889
Cohn DE, Dehdashti F, Gibb RK, Mutch DG, Rader JS, Siegel BA, Herzog TJ (2002) Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol 85:179–184
Peiró V, Chiva L, González A, Bratos R, Alonso S, Márquez R, Carballo N, Alonso-Farto JC (2014) Utility of the PET/CT in vulvar cancer management. Rev Esp Med Nucl Imagen Mol 33:87–92
Dittmer C, Fischer D, Diedrich K, Thill M (2012) Diagnosis and treatment options of vulvar cancer: a review. Arch Gynecol Obstet 285:183–193
McGee J, Covens A (2009) State of the art of sentinel lymph node biopsy in vulvar carcinoma. Womens Health (Lond Engl) 5:555–563
Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106:4–16
Ansink AC, Sie-Go DM, van der Velden J, Sijmons EA, de Barros Lopes A, Monaghan JM, Kenter GG, Murdoch JB, ten Kate FJ, Heintz AP (1999) Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection: a multicenter study. Cancer 86:652–656
Perry LJ, Guralp O, Al-Niaimi A, Zucker NA, Kushner DM (2013) False positive PET–CT scan and clinical examination in a patient with locally advanced vulvar cancer. Gynecol Oncol Case Rep 4:29–31
Kamran MW, O’Toole F, Meghen K, Wahab AN, Saadeh FA, Gleeson N (2014) Whole-body [18F]fluoro-2-deoxyglucose positron emission tomography scan as combined PET–CT staging prior to planned radical vulvectomy and inguinofemoral lymphadenectomy for squamous vulvar cancer: a correlation with groin node metastasis. Eur J Gynaecol Oncol 35:230–235
Freudenberg LS, Görtz E, Hagen C, Harms E, Koska WW, Marlowe RJ, Shadouh S, Stock C (2010) Lymphatic mapping using SPECT/CT in vulvar carcinoma. Clin Nucl Med 35:950–952
Balasubramanian Harisankar CN, Mittal BR, Bhattacharya A, Dhaliwal LK (2013) Utility of SPECT/CT in sentinel lymph node detection in a case of vulvar carcinoma. Mol Imaging Radionucl Ther 22:106–108
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors share no conflict of interest. This study was not supported by any person or institution.
Rights and permissions
About this article
Cite this article
Dolanbay, M., Ozcelik, B., Abdulrezzak, U. et al. F-18 fluoro-d-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers. Arch Gynecol Obstet 293, 1319–1324 (2016). https://doi.org/10.1007/s00404-015-3927-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-015-3927-3